Home » Topics » Regulatory » Patents

Patents
RSS

Antiproliferative quinazoline derivatives disclosed at Zeneca

Oct. 23, 1997

Abbott describes new endothelin antagonists

Oct. 23, 1997

Bradykinin antagonists from Pfizer

Oct. 23, 1997

ICAM-1/VCAM-1 inhibitors disclosed by Tanabe Seiyaku

Oct. 23, 1997

Sankyo isolates antibacterial agent F-12436

Oct. 23, 1997

BASF prepares anti-hTNF-alpha antibodies

Oct. 20, 1997

Prodrugs of selective COX-2 inhibitors

Oct. 20, 1997

Warner-Lambert prepares new cyclic amino acids related to gabapentin

Oct. 20, 1997

VZV vaccines using gene product expressed during latency

Oct. 17, 1997

Byk Gulden describes new agents for asthma

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 19, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 19, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...